medigraphic.com
ISSN 1405-1699 (Print)
Órgano Oficial del Colegio Mexicano de Alergia, Asma e Inmunología Pediátrica y de la Asociación Latinoamericana de Pediatría

2004, Number 1

<< Back Next >>

Alerg Asma Inmunol Pediatr 2004; 13 (1)

Cytokines and molecules in sepsis and in patients with sepsis and complications of neutropenia

Guzmán CB, Correa BD, Caballase UE, Calderón C

Language: Spanish
References: 31
Page: 15-23
PDF size: 108.76 Kb.


ABSTRACT

Neutropenia is high risk for sepsis in patients with cancer. The morbidity and mortality of sepsis have been directly correlated with increased levels of cytokines. Have been recently proved increased levels of cytokines in neutropenia and sepsis with diagnostic value.


REFERENCES

  1. Chanock S, Pizzo P. Infectious Disease Emergencies: Fever in the Neutropenic Host. Infect Dis Clin North Am 1996; 10(4): 762-78.

  2. Pizzo P. Management of fever in patients with cancer and treatment induced neutropenia. N Engl J Med 1993; 328: 1323-35.

  3. Cebon J, Layton JE, Maher D, Morstyn G, et al. Endogenous haemopoietic growth factors in neutropenia and infection. B J Haematol 1994; 86: 265-73.

  4. Damas P, Canivet J, De Groote D et al. Sepsis and serum cytokine concentrations. Crit Care Med 1997; 25(3): 405-412.

  5. Abraham E, Matthay M, Dinarello C et al. Consensus conference definitions for sepsis, septic shock, acute lung injury, and acute respiratory distress syndrome: Time for a reevaluation. 2000; 28(1): 232-37.

  6. Abbas A, Lichtman A, Pober J. Inmunología Celular y Molecular. Interamericana, 1995: 4, 10, 268-91, 308-10, 329-32.

  7. Fleisher T, Bleesing J. Primary Immune deficiencys: presentation, diagnosis and management. Immune function. Ped Clin North Am 2000; 47(6): 295-306.

  8. Reinhart K. Markers of endotelial damage in organ dysfunction and sepsis. Crit Care Med 2002; 30(5 Suppl): 302-12.

  9. Hack C, Zeerlerder S. The endothelium in sepsis: source of and a target of inflammation. Crit Care Med 2001; 29(7): 294-310.

  10. Marshall J. Inflammation, coagulopathy, and the pathogenesis of multiple organ dysfunction syndrome. Crit Care Med 2000; 29(7): 1323-36.

  11. Kayak S. Elevated circulating E selectin, intercellular adhesion molecule 1, and von Willebrand factor in patients with severe infection. American Journal of Respiratory and Crit Care Med 1998; 157(3): 776-84.

  12. Mesters R, Helterbrand J, Utterback B et al. Prognostic values of protein C concentrations in neutropenic patients at high risk of severe septic complications. Crit Care Med 2000; 28(7): 2209-16.

  13. Harbarth S, Holeckova K, Froidevaux C, Pittet D. Diagnostic value of procalcitonin, interleukin 6, and interleukin 8 in critically ill patients admitted with suspected sepsis. American Journal of Respiratory and Crit Care Med 2001; 164(3): 396-402.

  14. Boucher BA. Procalcitonin: Clinical tool or laboratory curiosity? Crit Care Med 2000; 28(4): 1224-32.

  15. Lehrnbecher Th, Venzon D, De Haas M, Chanock S. Assesment of Measuring Circulating levels of interleukin 6, Interleukin 8, C reactive protein, Soluble FC gamma receptor type III, and Mannose Binding protein in febrile children with cancer and neutropenia. Clin Infect Dis 1999; 29: 414-419.

  16. Taniguchi T, Koido Y, Jyunichi A et al. Change in the ratio of interleukin 6 to interleukin 10 predicts a poor outcome in patients with systemic inflammatory response syndrome. Crit Care Med 1999; 27(7): 1262-65.

  17. Borreli E, Roux P, Grau G et al. Plasma concentrations of cytokines, their soluble receptors and antioxidant vitamins can predict the development of multiple organ failure in patients at high risk. Crit Care Med 1996; 24(3): 227-42.

  18. Rintala E. Endotoxin, interleukin 6 and phospholipase A2 as markers of sepsis in patients with hematological malignancies. Scand J Infect Dis 1995; 27(1): 39-43.

  19. Friedland J, Daryanani J, Bland J et al. Plasma proinflammatory cytokine concentrations, Acute Physiology and Chronic Health Evaluation (APACHE) III scores and survival in patients in an intensive care unit. Crit Care Med 1996; 24(11): 1775-82.

  20. Barriere S, Lowry S. An overview of mortality risk prediction in sepsis. Crit Care Med 1995; 23(2): 376-95.

  21. Dinarello CH. Proinflammatory and anti-inflammatory cytokines as mediators in the pathogenesis of Septic Shock. Chest 1997; 112(6): 329-332.

  22. Presneill J, Waring P, Layton J et al. Plasma Granulocyte colony- stimulating factor levels in critical illness including sepsis and septic shock: Relation to disease severity, multiple organ dysfunction and mortality. Crit Care Med 2000; 28(7): 587-96.

  23. Nelson S, Bagby G. Granulocyte Colony-Stimulating factor and modulation of inflammatory cells in sepsis. Clin Chest Med 1996; 17(2): 319-32.

  24. Whalen D. Contrarregulatory control of the acute inflammatory response: Granulocyte colony-stimulating factor has anti-inflammatory properties. Crit Care Med 1999; 27(5): 1999, 1019-21.

  25. Kim S, Demetri G et al. Haematologic Complications of Cancer, Chemotherapy and Neutropenia. Haematol/Oncol Clin North Am 1996; 10(2): 377-95.

  26. Gross-Weege W, Dumon K, Dahmen A. Granulocyte colony-stimulating factor (G-CSF) serum levels in surgical intensive care patients. Infection 1997; 25: 213-16.

  27. Dhainaut J. Hepatic response to sepsis: interaction between coagulation and inflammatory processes. Crit Care Med 2001; 29(7): 1632-47.

  28. Shorr A, Thomas S, Alkins S et al. D-dimer correlates with proinflammatory cytokine levels and outcome in Critically Ill Patients. Chest 2002; 121(4): 1024-1036.

  29. Mesters RM, Manucci PM, Coppola R et al. Factor VIIa and antitrombin III activity during severe sepsis and septic shock in neutropenic patients. Blood 1996; 88: 881-886.

  30. Nawroth P, Stern D. Modulation of endotelial cell hemostatic properties by tumor necrosis factor. J Exp Med 1986; 163(3): 740-45.

  31. Zimmerman G, McIntyre T, Prescott S. The platelet-activating factor signaling system and its regulators in syndromes of inflammation and thrombosis. Crit Care Med 2000; 30(5): 758-72.




2020     |     www.medigraphic.com